Brief: MiMedx Group Says Robert Stein’s Position As President Of Regenerative Medicine Business Unit Eliminated, And He Will Be Departing From The Company
June 20 (Reuters) - MiMedx Group Inc MDXG.O :
* MIMEDX GROUP INC- ROBERT STEIN’S POSITION AS PRESIDENT OF
REGENERATIVE MEDICINE BUSINESS UNIT ELIMINATED, AND HE WILL BE
DEPARTING FROM THE COMPANY
Further company coverage: MDXG.O
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million